Sale!

Malaria P. Falciparum & P. Vivax Multiplex Detection Differentiation RNA Detection Qualitative Test

Original price was: $200.Current price is: $170.

-15%

The Malaria P. Falciparum & P. Vivax Multiplex Detection Differentiation RNA Detection Qualitative Test is a cutting-edge molecular diagnostic tool that uses Real Time RT-PCR technology to accurately identify and distinguish between Plasmodium falciparum and Plasmodium vivax malaria infections. This advanced test detects specific RNA sequences, providing superior sensitivity and specificity compared to traditional microscopy methods. It’s particularly valuable for patients experiencing fever, chills, headache, fatigue, and other malaria symptoms, especially those with recent travel to endemic regions. The test delivers results within 36-48 hours, enabling prompt treatment decisions. Available for $170 USD, this comprehensive diagnostic approach helps healthcare providers implement targeted antimalarial therapy and monitor treatment response effectively.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Malaria P. Falciparum & P. Vivax Multiplex Detection Differentiation RNA Detection Qualitative Test

Comprehensive Malaria Diagnosis Through Advanced Molecular Technology

The Malaria P. Falciparum & P. Vivax Multiplex Detection Differentiation RNA Detection Qualitative Test represents a significant advancement in malaria diagnostics, utilizing state-of-the-art Real Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) technology. This sophisticated molecular test provides unparalleled accuracy in detecting and differentiating between the two most clinically significant malaria species: Plasmodium falciparum and Plasmodium vivax.

What This Revolutionary Test Measures

This multiplex detection system specifically targets and amplifies unique RNA sequences from Plasmodium falciparum and Plasmodium vivax parasites. Unlike traditional methods that rely on microscopic examination, this test:

  • Detects specific RNA markers with exceptional precision
  • Differentiates between P. falciparum and P. vivax infections
  • Provides qualitative results indicating presence or absence of infection
  • Offers superior sensitivity even in low-parasite-density infections
  • Reduces false negatives common in conventional testing

Who Should Consider This Advanced Malaria Test?

Clinical Indications and Symptoms

This test is particularly recommended for individuals experiencing:

  • Fever with cyclical patterns (every 48-72 hours)
  • Severe chills and profuse sweating episodes
  • Persistent headaches and muscle aches
  • Fatigue and general malaise
  • Nausea, vomiting, or diarrhea
  • Recent travel to malaria-endemic regions
  • Unexplained anemia or jaundice
  • History of previous malaria infection

Significant Benefits of Molecular Malaria Detection

Why Choose RNA-Based Malaria Testing?

The Malaria P. Falciparum & P. Vivax Multiplex Detection Differentiation Test offers numerous advantages over traditional diagnostic methods:

  • Early Detection: Identifies infections before symptoms become severe
  • Species Differentiation: Crucial for selecting appropriate treatment regimens
  • High Sensitivity: Detects as few as 1-5 parasites per microliter of blood
  • Rapid Results: Turnaround time of 36-48 hours for prompt treatment decisions
  • Treatment Monitoring: Helps assess response to antimalarial therapy
  • Reduced Misdiagnosis: Minimizes confusion with other febrile illnesses

Understanding Your Test Results

Interpreting Molecular Malaria Detection

Your test results will provide clear, actionable information:

  • Positive for P. falciparum: Indicates infection with the most severe malaria species requiring immediate treatment
  • Positive for P. vivax: Suggests infection that may require additional treatment to prevent relapse
  • Negative Result: No detectable malaria RNA, though clinical correlation is essential
  • Mixed Infection: Rare cases showing both species, requiring comprehensive treatment

All results should be interpreted by your healthcare provider in the context of your clinical presentation, travel history, and other diagnostic findings.

Test Pricing and Availability

Test Name Discount Price Regular Price
Malaria P. Falciparum & P. Vivax Multiplex Detection Differentiation RNA Detection Qualitative Test $170 USD $200 USD

Nationwide Accessibility

We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible, high-quality malaria testing for patients nationwide.

Pre-Test Preparation Requirements

To ensure optimal testing conditions and accurate results:

  • Bring signed consent documentation
  • Provide complete clinical history including recent travel
  • No fasting required before sample collection
  • Sample type: Whole blood or dried blood spot
  • Results available: 4th working day via email (48 hours) or phone (36 hours)

Take Action Against Malaria Today

Don’t let uncertainty about malaria symptoms compromise your health. Early and accurate diagnosis is crucial for effective treatment and preventing complications. Our advanced molecular testing provides the clarity you need for proper medical management.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your Malaria P. Falciparum & P. Vivax Multiplex Detection Differentiation RNA Detection Qualitative Test. Our experienced healthcare professionals are ready to assist you with convenient appointment scheduling and answer any questions about this sophisticated diagnostic approach.

Trust in our commitment to excellence in infectious disease diagnostics. With cutting-edge technology and nationwide accessibility, we provide the reliable answers you need for informed healthcare decisions.